Migraine treatment device gets US approval

Israel’s Theranica (reported here previously) has received US FDA clearance to market its Nerivio therapeutic device for the acute treatment of episodic or chronic migraine in people 12 years and older. Theranica’s migraine patch was approved by the FDA in 2019.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *